You are viewing: Spain Brain Monitoring Market analysis
Part of: Brain Monitoring Market (Global)

The Spain Brain Monitoring Market was valued at $68.1 Million in 2023 and projected to reach to $78.3 Million by 2028, representing a compound annual growth rate of 2.8%. Spain's brain monitoring market is positioned for steady growth driven by modernization of healthcare infrastructure and rising neurological disease prevalence.

Spain Brain Monitoring Market (2023-2028) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Spain Brain Monitoring Market Trends and Insights

  • This moderate growth trajectory reflects Spain's advancing healthcare infrastructure and increasing adoption of neurological diagnostic technologies across hospitals and specialized clinics.
  • Spain's market expansion is driven by rising prevalence of neurological disorders, aging demographics, and growing investment in medical device innovation within the Spanish healthcare system. The Spanish brain monitoring sector benefits from strong regulatory frameworks and integration with the European Union's medical device standards.
  • Spain's healthcare providers are increasingly deploying advanced monitoring solutions for conditions such as epilepsy, sleep disorders, and neurodegenerative diseases.
  • Between 2023 and 2028, Spain is expected to see steady demand for both invasive and non-invasive brain monitoring technologies, supported by clinical research initiatives and improved reimbursement policies within Spain's national health system..

Key Market Statistics

  • CAGR (2023-2028) 2.8% CAGR
  • Market Size, 2023 ~USD 68.1 Million
  • Forecast, 2028 ~USD 78.3 Million
  • Country Spain

Spain Brain Monitoring Market Overview

Market Valuation :

Spain's brain monitoring market reached $68.1 million in 2023, with projected growth to $78.3 million by 2028, representing a steady expansion in neurological diagnostic capabilities across the country.

Healthcare Infrastructure Growth :

Spain's advancing healthcare system is increasingly integrating brain monitoring technologies into hospitals and specialized neurology clinics, supporting improved patient diagnostics and treatment outcomes.

Moderate but Stable CAGR :

At 2.8% CAGR through 2028, Spain's market demonstrates consistent, sustainable growth that lags the global rate of 6.3%, reflecting a more conservative adoption pace in the Spanish healthcare sector.

Neurological Diagnostic Adoption :

Increasing prevalence of neurological disorders and growing awareness among Spanish healthcare providers are driving demand for advanced brain monitoring solutions in clinical and hospital settings.

Spain Brain Monitoring Market Dynamics

  • The country's healthcare system continues to invest in diagnostic technologies, with hospitals and specialized clinics increasingly adopting brain monitoring solutions for improved patient care and clinical outcomes.
  • While growth remains moderate compared to global trends, Spain's market reflects a maturing healthcare economy with strong fundamentals.
  • Over the forecast period through 2028, expansion will be supported by aging demographics, increased neurological disorder diagnoses, and healthcare provider investments in advanced diagnostic capabilities.
  • The Spanish market represents a stable opportunity for vendors focused on sustainable, long-term growth in Western European healthcare..

Related Ecosystem

Diagnostic Imaging

Top Technologies
  • Magnetic Resonance Imaging (MRI)
  • Computed Tomography (CT)
  • CT Scanners
  • Nuclear Imaging
  • Positron Emission Tomography
Top Companies
  • Siemens healthineers
  • PHILIPS HEALTHCARE
  • CANON INC.
  • FUJIFILM Holdings Corporation
  • UNITED IMAGING HEALTHCARE CO., LTD.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • JOHNSON & JOHNSON

      Key Takeaways

      • Spain's brain monitoring market reached $68.1 million in 2023 with a projected value of $78.3 million by 2028.
      • Spain is experiencing a 2.8% CAGR, reflecting steady but moderate growth compared to global expansion rates.
      • Spain's aging population and rising neurological disorder prevalence are primary drivers of market expansion.
      • Spain's integration with EU medical device regulations supports adoption of advanced monitoring technologies.

      Brain Monitoring Market Report Scope

      Report Metric Details
      Base Year 2023
      Fastest Growing Segment CEREBRAL OXIMETERS (Type)
      Forecast Period 2023–2028
      Growth Rate CAGR of 6.3% from 2023 to 2028
      Largest Segment NON-INVASIVE PROCEDURES (Procedure)
      Market Size Base Year (Billions) ~USD 3.54 (2023)
      Revenue Forecast (Billions) ~USD 4.8 (2028)
      Segments Covered Product, Type, Usability, Procedure, Modality, Medical Condition, End User

      Spain Brain Monitoring Market Report Segmentation

      7 segment dimensions are covered across the global market.

      By Product

      • Accessories
      • Devices

      By Type

      • Batteries
      • Cables
      • Caps
      • Cerebral Oximeters
      • Ct Scanners
      • Dry Electrodes
      • Eeg Devices
      • Electrodes
      • Emg Devices
      • Icp Monitors
      • Meg Devices
      • Mri Scanners
      • Needle Electrodes
      • Other Accessories
      • Pastes & Gels
      • Pet Scanners
      • Sensors
      • Sleep Monitoring Devices
      • Tcd Devices
      • Wet Electrodes

      By Usability

      • Disposable Accessories
      • Non- Disposable Accessories
      • Non-Disposable Accessories

      By Procedure

      • Invasive Procedures
      • Non-Invasive Procedures

      By Modality

      • Fixed Devices
      • Portable Devices
      • Wearable Devices

      By Medical Condition

      • Dementia
      • Epilepsy
      • Headache Disorders
      • Huntington'S Disease
      • Other Medical Conditions
      • Parkinson'S Disease
      • Sleep Disorders
      • Stroke
      • Traumatic Brain Injury

      By End User

      • Ambulatory Surgery Centers & Clinics
      • Diagnostic Centers
      • Diagnostic Centres
      • Hospitals
      • Neurological Centers
      • Neurological Centres
      • Other End Users

      SPAIN: BRAIN MONITORING MARKET, BY END USER, 2021–2028

      Segment20212022202320242025202620272028CAGR (%)
      AMBULATORY SURGERY CENTERS & CLINICS8.198.59.039.439.8710.2710.711.134.3
      DIAGNOSTIC CENTRES2.712.792.943.053.173.283.393.53.6
      HOSPITALS49.8350.9853.454.9656.7358.2659.8561.352.8
      NEUROLOGICAL CENTRES15.616.2617.3518.1919.1320.0220.9521.884.7
      OTHER END USERS7.337.387.627.727.857.948.038.111.3
      TOTAL83.785.990.393.496.799.8102.91063.2

      Target Audience

      • Medical Device Manufacturers : Brain monitoring device companies need Spain-specific market data to assess market size, growth potential, competitive intensity, and optimal go-to-market strategies for Spanish healthcare providers.
      • Healthcare Investors & PE Firms : Investment professionals require detailed Spain market analysis to evaluate acquisition targets, portfolio company growth prospects, and regional expansion opportunities in neurological diagnostics.
      • Hospital & Clinic Administrators : Spanish healthcare facility leaders need market intelligence to benchmark technology adoption rates, justify capital investments in brain monitoring equipment, and plan neurology service expansion.
      • Market Entry Consultants : Strategy and consulting firms advising clients on Spain healthcare expansion require localized market data, growth forecasts, and competitive dynamics to develop credible market entry plans.
      • Healthcare Technology Distributors : Spanish and European distributors need country-level market sizing and growth projections to allocate resources, negotiate supplier agreements, and forecast revenue from brain monitoring product lines.

      Key Companies in the Spain Brain Monitoring Market

      CompanyHQOwnershipStrongest segments
      CONMED CORPORATIONUnited StatesPublic CompanyOrthopedic and Sports Medicine (BioBrace, Y-Knot, Hall power tools, arthroscopy ecosystem),General Surgery (AirSeal, Buffalo Filter, endomechanical, electrosurgery),Endoscopic Technologies and Patient Monitoring,
      NATUS MEDICAL INCORPORATEDUnited StatesPrivate CompanyNeurodiagnostic systems (EEG, EMG, ICU monitoring, polysomnography, intra-operative monitoring),Newborn care (hearing screening, jaundice management, brain injury, NICU essentials, NICVIEW),Audiology, otoneurologic, and vestibular systems,
      NIHON KOHDEN CORPORATIONJapanPublic CompanyPatient monitors & clinical information systems,Physiological measuring equipment (EEG/ECG/EMG and related),Defibrillators, AEDs, ventilators, anesthesia and related devices,
      GE HEALTHCAREUnited StatesPublic CompanyImaging,Advanced Visualization Solutions (AVS),Patient Care Solutions (PCS),
      SIEMENS HEALTHINEERS AGGermanyPublic CompanyImaging,Diagnostics,Varian (Oncology),
      COMPUMEDICS LIMITEDAustraliaPublic CompanySleep diagnostics (PSG, HST, Somfit),Neurology diagnostics (EEG, LTM, ambulatory),Brain research & MEG systems,
      MEDTRONICIrelandPublic CompanyCardiovascular Portfolio,Neuroscience Portfolio,Medical Surgical Portfolio (incl. Surgical, Monitoring, Diabetes),
      EDWARDS LIFESCIENCES CORPORATIONUnited StatesPublic CompanyTranscatheter aortic valve replacement (SAPIEN family),Transcatheter mitral and tricuspid (PASCAL, EVOQUE),Surgical structural heart (INSPIRIS, RESILIA, KONECT, MITRIS),
      CGXCanadaPublic CompanyFilm Entertainment and Content (theatrical, Event Cinema, food service),Media (on-screen, digital signage, advertising solutions),Location-Based Entertainment (Rec Room, Playdium, Junxion, in-theatre gaming),

      CONMED CORPORATION

      CONMED Corporation is a publicly traded U.S. medical device company founded in 1970 with approximately 3,900 employees.

      NATUS MEDICAL INCORPORATED

      Natus Medical Incorporated is a U.S.-based private company founded in 1987 with 1,400 employees specializing in medical devices and monitoring solutions.

      NIHON KOHDEN CORPORATION

      Nihon Kohden Corporation is a Japanese public company founded in 1951 with 6,116 employees, operating in the medical device and healthcare technology industry.

      GE HEALTHCARE

      GE Healthcare is a publicly traded U.S. company established in 2022 with 54,000 employees, providing healthcare technology and solutions.

      SIEMENS HEALTHINEERS AG

      Siemens Healthineers AG is a German public company with roots dating to 1896 and 72,369 employees, operating as a global leader in medical technology and diagnostics.

      COMPUMEDICS LIMITED

      Compumedics Limited is an Australian publicly traded company founded in 1987 with 175 employees, specializing in medical device manufacturing.

      MEDTRONIC

      Medtronic is a publicly traded company founded in Ireland in 1949 with 95,000 employees, serving as a global leader in medical technology and healthcare solutions.

      EDWARDS LIFESCIENCES CORPORATION

      Edwards Lifesciences Corporation is a U.S. public company founded in 1958 with 16,000 employees, specializing in cardiovascular and critical care medical devices.

      CGX

      CGX is a Canadian public company founded in 1912 with 10,000 employees operating across multiple business sectors.

      Reasons to Buy this Report

      • Country-Specific Market Sizing : Obtain precise valuation data for Spain's brain monitoring market with verified 2023 baseline ($68.1M) and 2028 forecasts ($78.3M), enabling accurate business planning and investment decisions.
      • Competitive Landscape Intelligence : Understand Spain's unique market dynamics, healthcare infrastructure adoption patterns, and regional competitive positioning distinct from broader European or global market trends.
      • Growth Trajectory Analysis : Analyze Spain's 2.8% CAGR in context of global 6.3% growth to identify market maturity levels, expansion opportunities, and strategic entry or expansion timing for your organization.
      • Healthcare Provider Insights : Access detailed understanding of Spanish hospital and clinic adoption rates for brain monitoring technologies, supporting targeted sales strategies and partnership development.
      • Regulatory and Market Context : Gain Spain-specific insights into healthcare regulations, reimbursement frameworks, and clinical adoption drivers essential for market entry, product positioning, and revenue forecasting.

      Frequently asked questions

      What is the current size of Spain's brain monitoring market?

      Spain's brain monitoring market was valued at $68.1 million in 2023 and is expected to reach $78.3 million by 2028.

      What is the growth rate for brain monitoring in Spain?

      Spain's brain monitoring market is growing at a compound annual growth rate (CAGR) of 2.8% from 2023 to 2028.

      What factors are driving growth in Spain's brain monitoring market?

      Key drivers include Spain's aging population, increasing prevalence of neurological disorders, advancing healthcare infrastructure, and improved reimbursement policies within Spain's national health system.

      Which neurological conditions are most monitored in Spain?

      Spain's brain monitoring applications include epilepsy management, sleep disorder diagnosis, neurodegenerative disease monitoring, and general neurological assessment in clinical settings.

      How does Spain's market compare to the global brain monitoring market?

      Spain's 2.8% CAGR is lower than the global 6.3% CAGR, indicating more conservative growth but stable market development aligned with European healthcare standards.

      RESEARCH METHODOLOGY

      The study involved four major activities in estimating the current size of the Brain Monitoring market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.

      Secondary Research

      This research study involved the extensive usage of secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers and annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain monitoring market. It was also used to obtain important information about the key market players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information important for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related executives from various key companies and organizations operating in the brain monitoring market. After the complete market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

      Some of the major objectives of primary research are:

      • To validate market segmentation defined through an assessment of the product portfolios of leading players
      • To understand the key industry trends and technologies defining the strategic growth objectives of market players
      • To gather both demand- and supply-side validation of the key factors affecting the market growth
      • To validate assumptions for the market sizing and forecasting model used for this study
      • To understand the market position of leading players in the brain monitoring market and their market share/ranking

      Breakdown Of Primary Participants

      Brain Monitoring Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.

      Note: Tiers are defined based on a company’s total revenue. As of 2019, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the Brain Monitoring market. These methods were also used extensively to estimate the size of various subsegments in the market.

      Bottom-up approach

      The bottom-up procedure was adopted to arrive at the overall size of the Brain Monitoring market from the revenue of key players (companies), their shares in the market, and their annual sales of Brain Monitoring products.

      Brain Monitoring Market Size, and Share

      To know about the assumptions considered for the study, Request for Free Sample Report

      Top-down approach

      The overall Brain Monitoring market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, medical condition, end user, and region) through percentage splits from secondary and primary research.

      For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.

      Brain Monitoring Market Size, and Share

      Data Triangulation

      After arriving at the overall market size, from the market size estimation process explained above, the Brain Monitoring market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the Brain Monitoring industry.

      Market Definition

      Brain Monitoring is a procedure that monitors the activity of various parameters associated with the functioning of brain, which includes electrical activity, blood flow, magnetic activity, the pressure surrounding the brain, and cerebral oxygen saturation.

      Key Stakeholders

      • World Health Organization (WHO)
      • National Center for Biotechnology Information (NCBI)
      • World Federation of Neurology (WFN)
      • Centers for Disease Control and Prevention (CDC)
      • Epilepsy Foundation
      • American Brain Foundation (ABF)
      • Brain Injury Association of America (BIAA)
      • Neurology Asia Journal
      • Alzheimer's Association
      • American Neurological Association (ANA)
      • European Journal of Neurology

      Report Objectives

      • To define, describe, and forecast the brain monitoring market based on the product, procedure, modality, medical condition, end user, and region.
      • To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges).
      • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall brain monitoring market.
      • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders.
      • To profile the key players in the market and comprehensively analyze their market shares and core competencies.
      • To forecast the size of the market segments with respect to four main regions, namely, North America, Asia Pacific, Europe, Latin America, and Middle East & Africa.
      • To track and analyze competitive developments such as new product launches, agreements, collaborations, and expansions.

      Available Customizations:

      MarketsandMarkets offers the following customizations for this market report:

      Company Information

      • Profiling of additional market players (up to 3)
      • Additional country-level analysis of sub-segments such as media, reagents, flow cytometers, and centrifuges.

      Get the Full Brain Monitoring Market Report

      Full forecast, segment splits, and company analysis for all Brain Monitoring Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status